Transforming disease and drug research
AI driven computational disease models
"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "
"“We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI Platform is a mandatory input to our target evaluation meetings”"
"“The proposed mechanism of action was very attractive. The Euretos team helped to explain the phenomenon as it was observed in mouse studies. We are very grateful for this report which has provided us with a lot of very useful information.”"
"“it really does show the value of having an independent set of eyes interpreting the data that we all have been staring at for years.”"
We work closely together with many pharmaceutical & biotech companies across all stages of the drug development cycle. We leverage disease models that provide unique insights into which molecular perturbations cause cell type and tissue level dysfunction and predict their effect on phenotypes and diseases and, ultimately, drug efficacy and safety.
Discover novel targets and markers based on their molecular interaction in the systems biological dysregulation profile of diseases.
Discover novel indications for compounds and targets based on their impact on dysregulation in thousands of Euretos-generated disease models
Leverage target and phenotypic correlations from our disease models to explain observed and predict potential side effects of your compound